Register entry

POLYGEN PHARMACEUTICALS INC.

Registered sites
1
Drug products
10
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingLabellingFinished drug manufacturePackagingRelabellingRepackaging
Sites

Facilities

1
SiteLocationOperationsFEI
POLYGEN PHARMACEUTICALS INC.Edgewood, NYUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging3008383084
Catalogue

Marketed products

10

Showing 10 of 10.

BrandGeneric nameFormCategory
ClopidogrelClopidogrelTABLETANDA
DarifenacinDarifenacin HydrobromideTABLET, EXTENDED RELEASEANDA
DarifenacinDarifenacin HydrobromideTABLET, EXTENDED RELEASEANDA
Memantine hydrochlorideMemantine hydrochlorideTABLET, FILM COATEDANDA
Phentermine hydrochloridePhentermine hydrochlorideTABLETANDA
amlodipine besylateamlodipine besylateTABLETANDA
amlodipine besylateamlodipine besylateTABLETANDA
amlodipine besylateamlodipine besylateTABLETANDA
clopidogrelclopidogrelTABLETANDA
memantine hydrochloridememantine hydrochlorideTABLET, FILM COATEDANDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.